Form 4: Molina Healthcare Director Ronna Romney Acquires Shares Under Equity Incentive Plan

Director Ronna Romney acquired 136 shares of Molina Healthcare common stock on April 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

• Ronna Romney, a director of Molina Healthcare, Inc., acquired 136 shares of common stock on April 1, 2024.
• The acquisition was made under the company's 2019 Equity Incentive Plan.
• The price per share was $404.20, based on the closing price of Molina Healthcare's common stock on that day.
• The shares were granted as part of the annual equity award to each director, with one quarter of the $220,000 annual award granted each quarter.
• Following the transaction, Ronna Romney beneficially owns 17,195 shares indirectly through a trust.
• Jeff D. Barlow, acting as attorney-in-fact, signed the Form 4 on behalf of Ronna Romney.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing governance structure. The sentiment is neutral to slightly positive as it reflects standard practice.

Positives

• The equity incentive plan aligns director interests with shareholder value.
• The grant of shares to a director demonstrates confidence in the company's future performance.

Future Outlook

There is no specific future outlook provided in this document.

Industry Context

This filing is a routine disclosure related to director compensation and is common among publicly traded companies. It reflects standard practices for aligning the interests of board members with those of shareholders through equity-based compensation.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across the healthcare industry.
• Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize equity grants as part of their director compensation packages.
• The specific value and structure of these grants vary based on company size, performance, and compensation philosophy.
• The $220,000 annual equity award appears to be within a reasonable range for directors of companies with a similar market capitalization to Molina Healthcare.

Stakeholder Impact

• Shareholders may view the equity grant positively as it aligns director interests with company performance.
• Employees may see it as a sign of stability and commitment from the board.

Key Dates